<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-222-2-75-88</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2584</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОР</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW</subject></subj-group></article-categories><title-group><article-title>Противовоспалительные и антимикробные свойства некоторых метаболитов солодки</article-title><trans-title-group xml:lang="en"><trans-title>Anti-inflammatory and antimicrobial properties of some licorice metabolites</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7308-7280</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хавкин</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Khavkin</surname><given-names>A. I.</given-names></name></name-alternatives><email xlink:type="simple">khavkin@nikid.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8364-6066</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Николайчук</surname><given-names>К. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikolaychuk</surname><given-names>K. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3606-4068</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шрайнер</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shreiner</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-7479-8277</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новикова</surname><given-names>М. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikova</surname><given-names>M. F.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-9228-2350</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Веременко</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Veremenko</surname><given-names>A. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-7317-6077</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Левченко</surname><given-names>И. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Levchenko</surname><given-names>I. D.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-0793-4236</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вергунова</surname><given-names>Е. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Vergunova</surname><given-names>E. E.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-1138-6049</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тумас</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Tumas</surname><given-names>A. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-1880-9585</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Платонова</surname><given-names>П. Я.</given-names></name><name name-style="western" xml:lang="en"><surname>Platonova</surname><given-names>P. Ya.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5468-9961</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пономаренко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ponomarenko</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-7808-1000</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пак</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pak</surname><given-names>I. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9494-4234</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Покушалов</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pokushalov</surname><given-names>E. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский клинический институт детства Министерства здравоохранения Московской области; Белгородский государственный исследовательский университет Министерства науки и высшего образования Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Clinical Institute of Childhood, Ministry of Health of the Moscow Region; Belgorod State Research University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Новосибирский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Новосибирский государственный университет; Институт химической биологии и фундаментальной медицины СО РАН; ГК Центр Новых медицинских технологий; “Soloways” лаборатория</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk State University; Institute of chemical, Institute of Chemical Biology and Fundamental Medicine of the SB RAS; Group of companies “Center for new medical technologies” Russia; “Soloways” laboratory</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Институт химической биологии и фундаментальной медицины СО РАН; ГК Центр Новых медицинских технологий; “Soloways” лаборатория</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of chemical, Institute of Chemical Biology and Fundamental Medicine of the SB RAS; Group of companies “Center for new medical technologies” Russia; “Soloways” laboratory</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ГК Центр Новых медицинских технологий; “Soloways” лаборатория</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Group of companies “Center for new medical technologies” Russia; “Soloways” laboratory</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>26</day><month>03</month><year>2024</year></pub-date><volume>0</volume><issue>2</issue><fpage>75</fpage><lpage>88</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хавкин А.И., Николайчук К.М., Шрайнер Е.В., Новикова М.Ф., Веременко А.С., Левченко И.Д., Вергунова Е.Е., Тумас А.С., Платонова П.Я., Пономаренко А.В., Пак И.А., Покушалов Е.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Хавкин А.И., Николайчук К.М., Шрайнер Е.В., Новикова М.Ф., Веременко А.С., Левченко И.Д., Вергунова Е.Е., Тумас А.С., Платонова П.Я., Пономаренко А.В., Пак И.А., Покушалов Е.А.</copyright-holder><copyright-holder xml:lang="en">Khavkin A.I., Nikolaychuk K.M., Shreiner E.V., Novikova M.F., Veremenko A.S., Levchenko I.D., Vergunova E.E., Tumas A.S., Platonova P.Y., Ponomarenko A.V., Pak I.A., Pokushalov E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2584">https://www.nogr.org/jour/article/view/2584</self-uri><abstract><p>В данной статье освещается фармакологическая активность метаболитов солодки, представляющих собой значимый интерес в контексте лечения онкологических, сердечно-сосудистых, респираторных заболеваний. В обзоре подробно рассмотрены многообразие и эффективность лихалокона, изоликвиритигенина, ликвиритигенина и других метаболитов солодки, которые демонстрируют противовоспалительные, антимикробные, антиоксидантные. В основе данных эффектов лежит способность метаболитов солодки регулировать молекулярные каскады, обуславливающие апоптоз, клеточный цикл, пролиферацию клеток и многие другие процессы. В статье подробно рассматриваются перспективы использования метаболитов солодки в онкологии, кардиологии их потенциал в создании новых лекарственных препаратов и необходимость дальнейших исследований для определения их полного терапевтического потенциала.</p></abstract><trans-abstract xml:lang="en"><p>This article highlights the pharmacological activity of licorice metabolites of significant interest in the context of the treatment of cancer, cardiovascular, and respiratory diseases. The review details the diversity and efficacy of lichalocone, isoliquiritigenin, liquiritigenin, and other licorice metabolites that exhibit anti-inflammatory, antimicrobial, and antioxidant effects. These effects are based on the ability of licorice metabolites to regulate molecular cascades responsible for apoptosis, cell cycle, cell proliferation and many other processes. The article discusses in detail the prospects for the use of licorice metabolites in oncology, cardiology, their potential in the development of new drugs and the need for further research to determine their full therapeutic potential.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>метаболический синдром</kwd><kwd>солодка</kwd><kwd>метаболиты солодки</kwd><kwd>лихалокон</kwd><kwd>изоликвиритигенин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>metabolic syndrome</kwd><kwd>licorice</kwd><kwd>licorice metabolites</kwd><kwd>lichalcone</kwd><kwd>isoliquiritigenin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Wahab S, Annadurai S, Abullais SS, Das G, Ahmad W, Ahmad MF et al. Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology. Plants (Basel). 2021 Dec 14;10(12):2751. doi: 10.3390/plants10122751.</mixed-citation><mixed-citation xml:lang="en">Wahab S, Annadurai S, Abullais SS, Das G, Ahmad W, Ahmad MF et al. Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology. Plants (Basel). 2021 Dec 14;10(12):2751. doi: 10.3390/plants10122751.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gaur R, Yadav KS, Verma RK, Yadav NP, Bhakuni RS. In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin. Phytomedicine. 2014 Mar 15;21(4):415-22. doi: 10.1016/j.phymed.2013.10.015.</mixed-citation><mixed-citation xml:lang="en">Gaur R, Yadav KS, Verma RK, Yadav NP, Bhakuni RS. In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin. Phytomedicine. 2014 Mar 15;21(4):415-22. doi: 10.1016/j.phymed.2013.10.015.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Xiaoying W, Han Z, Yu W. Glycyrrhiza glabra (Licorice): ethnobotany and health benefits. Sustained energy for enhanced human functions and activity. Academic Press. 2017: 231-250. doi: 10.1016/B978-0-12-805413-0.00014-4</mixed-citation><mixed-citation xml:lang="en">Xiaoying W, Han Z, Yu W. Glycyrrhiza glabra (Licorice): ethnobotany and health benefits. Sustained energy for enhanced human functions and activity. Academic Press. 2017: 231-250. doi: 10.1016/B978-0-12-805413-0.00014-4</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Alsayari A, Wahab S. Genus Ziziphus for the treatment of chronic inflammatory diseases. Saudi J Biol Sci. 2021 Dec;28(12):6897-6914. doi: 10.1016/j.sjbs.2021.07.076.</mixed-citation><mixed-citation xml:lang="en">Alsayari A, Wahab S. Genus Ziziphus for the treatment of chronic inflammatory diseases. Saudi J Biol Sci. 2021 Dec;28(12):6897-6914. doi: 10.1016/j.sjbs.2021.07.076.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bao F, Bai HY, Wu ZR, Yang ZG. Phenolic compounds from cultivated Glycyrrhiza uralensis and their PD-1/PD-L1 inhibitory activities. Nat Prod Res. 2021 Feb;35(4):562-569. doi: 10.1080/14786419.2019.1586698.</mixed-citation><mixed-citation xml:lang="en">Bao F, Bai HY, Wu ZR, Yang ZG. Phenolic compounds from cultivated Glycyrrhiza uralensis and their PD-1/PD-L1 inhibitory activities. Nat Prod Res. 2021 Feb;35(4):562-569. doi: 10.1080/14786419.2019.1586698.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tang ZH, Li T, Tong YG, Chen XJ, Chen XP, Wang YT, Lu JJ. A Systematic Review of the Anticancer Properties of Compounds Isolated from Licorice (Gancao). Planta Med. 2015 Dec;81(18):1670-87. doi: 10.1055/s-0035-1558227.</mixed-citation><mixed-citation xml:lang="en">Tang ZH, Li T, Tong YG, Chen XJ, Chen XP, Wang YT, Lu JJ. A Systematic Review of the Anticancer Properties of Compounds Isolated from Licorice (Gancao). Planta Med. 2015 Dec;81(18):1670-87. doi: 10.1055/s-0035-1558227.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Graebin C. S. The Pharmacological Activities of Glycyrrhizinic Acid (“Glycyrrhizin”) and Glycyrrhetinic Acid. In: Mérillon, JM., Ramawat, K. (eds) Sweeteners. Reference Series in Phytochemistry. Springer, Cham. 2018. doi: 10.1007/978-3-319-27027-2_15.</mixed-citation><mixed-citation xml:lang="en">Graebin C. S. The Pharmacological Activities of Glycyrrhizinic Acid (“Glycyrrhizin”) and Glycyrrhetinic Acid. In: Mérillon, JM., Ramawat, K. (eds) Sweeteners. Reference Series in Phytochemistry. Springer, Cham. 2018. doi: 10.1007/978-3-319-27027-2_15.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Okimasu E, Moromizato Y, Watanabe S, Sasaki J, Shiraishi N, Morimoto YM, Miyahara M, Utsumi K. Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug. Acta Med Okayama. 1983 Oct;37(5):385-91. doi: 10.18926/AMO/32426.</mixed-citation><mixed-citation xml:lang="en">Okimasu E, Moromizato Y, Watanabe S, Sasaki J, Shiraishi N, Morimoto YM, Miyahara M, Utsumi K. Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug. Acta Med Okayama. 1983 Oct;37(5):385-91. doi: 10.18926/AMO/32426.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Simmler C, Pauli GF, Chen SN. Phytochemistry and biological properties of glabridin. Fitoterapia. 2013 Oct;90:160-84. doi: 10.1016/j.fitote.2013.07.003.</mixed-citation><mixed-citation xml:lang="en">Simmler C, Pauli GF, Chen SN. Phytochemistry and biological properties of glabridin. Fitoterapia. 2013 Oct;90:160-84. doi: 10.1016/j.fitote.2013.07.003.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Anand David AV, Arulmoli R, Parasuraman S. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid. Pharmacogn Rev. 2016 Jul-Dec;10(20):84-89. doi: 10.4103/0973-7847.194044.</mixed-citation><mixed-citation xml:lang="en">Anand David AV, Arulmoli R, Parasuraman S. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid. Pharmacogn Rev. 2016 Jul-Dec;10(20):84-89. doi: 10.4103/0973-7847.194044.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu X, Shi J, Li H. Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-κB and NLRP3 inflammasome pathways. Biomed Pharmacother. 2018 Oct;106:976-982. doi: 10.1016/j.biopha.2018.07.045.</mixed-citation><mixed-citation xml:lang="en">Zhu X, Shi J, Li H. Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-κB and NLRP3 inflammasome pathways. Biomed Pharmacother. 2018 Oct;106:976-982. doi: 10.1016/j.biopha.2018.07.045.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mazur J, Roy K, Shigdar S. et all. Efficacy of promising flavonoids from Festuca, Lonicera, and Acacia genera against glioblastoma multiforme; potential for the Dandenong Ranges. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. 2020 Apr; 383-422. doi: 10.1016/B978-0-12-819666-3.00013-4;</mixed-citation><mixed-citation xml:lang="en">Mazur J, Roy K, Shigdar S. et all. Efficacy of promising flavonoids from Festuca, Lonicera, and Acacia genera against glioblastoma multiforme; potential for the Dandenong Ranges. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. 2020 Apr; 383-422. doi: 10.1016/B978-0-12-819666-3.00013-4;</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Peng F, Du Q, Peng C, Wang N, Tang H, Xie X, Shen J, Chen J. A Review: The Pharmacology of Isoliquiritigenin. Phytother Res. 2015 Jul;29(7):969-77. doi: 10.1002/ptr.5348.</mixed-citation><mixed-citation xml:lang="en">Peng F, Du Q, Peng C, Wang N, Tang H, Xie X, Shen J, Chen J. A Review: The Pharmacology of Isoliquiritigenin. Phytother Res. 2015 Jul;29(7):969-77. doi: 10.1002/ptr.5348.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang J, Zhang X, True AD, Zhou L, Xiong YL. Inhibition of lipid oxidation and rancidity in precooked pork patties by radical-scavenging licorice (Glycyrrhiza glabra) extract. J Food Sci. 2013 Nov;78(11): C1686-94. doi: 10.1111/1750-3841.12273.</mixed-citation><mixed-citation xml:lang="en">Jiang J, Zhang X, True AD, Zhou L, Xiong YL. Inhibition of lipid oxidation and rancidity in precooked pork patties by radical-scavenging licorice (Glycyrrhiza glabra) extract. J Food Sci. 2013 Nov;78(11): C1686-94. doi: 10.1111/1750-3841.12273.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Martins N, Barros L, Dueñas M et all. Characterization of phenolic compounds and antioxidant properties of Glycyrrhiza glabra L. rhizomes and roots. RSC Advances. 2015 Jun; 5(34):26991-26997. doi: 10.1039/C5RA03963K.</mixed-citation><mixed-citation xml:lang="en">Martins N, Barros L, Dueñas M et all. Characterization of phenolic compounds and antioxidant properties of Glycyrrhiza glabra L. rhizomes and roots. RSC Advances. 2015 Jun; 5(34):26991-26997. doi: 10.1039/C5RA03963K.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Xie J, Zhang U, Wang W et all. Identification and simultaneous determination of glycyrrhizin, formononetin, glycyrrhetinic acid, liquiritin, isoliquiritigenin, and licochalcone A in licorice by LC-MS/MS. Acta Chromatographica. 2014 Sep; 26(3):507-516. doi: 10.1556/achrom.26.2014.3.9.</mixed-citation><mixed-citation xml:lang="en">Xie J, Zhang U, Wang W et all. Identification and simultaneous determination of glycyrrhizin, formononetin, glycyrrhetinic acid, liquiritin, isoliquiritigenin, and licochalcone A in licorice by LC-MS/MS. Acta Chromatographica. 2014 Sep; 26(3):507-516. doi: 10.1556/achrom.26.2014.3.9.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Alagarsamy V, Raja Solomon V, Sulthana MT et all. Screening Active Phytochemicals of Some Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Mpro by Computational Investigation. Letters in Drug Design &amp; Discovery. 2023; 20(9):1380-1392. doi: 10.2174/1570180819666220929151127.</mixed-citation><mixed-citation xml:lang="en">Alagarsamy V, Raja Solomon V, Sulthana MT et all. Screening Active Phytochemicals of Some Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Mpro by Computational Investigation. Letters in Drug Design &amp; Discovery. 2023; 20(9):1380-1392. doi: 10.2174/1570180819666220929151127.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Fatoki TH, Ajiboye BO, Aremu AO. In Silico Evaluation of the Antioxidant, Anti-Inflammatory, and Dermatocosmetic Activities of Phytoconstituents in Licorice (Glycyrrhiza glabra L.). Cosmetics. 2023; 10(3):69. doi: 10.3390/cosmetics10030069.</mixed-citation><mixed-citation xml:lang="en">Fatoki TH, Ajiboye BO, Aremu AO. In Silico Evaluation of the Antioxidant, Anti-Inflammatory, and Dermatocosmetic Activities of Phytoconstituents in Licorice (Glycyrrhiza glabra L.). Cosmetics. 2023; 10(3):69. doi: 10.3390/cosmetics10030069.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sharifi-Rad J, Quispe C, Herrera-Bravo J, Belén LH, Kaur R, Kregiel D, Uprety Y et al. Glycyrrhiza Genus: Enlightening Phytochemical Components for Pharmacological and Health-Promoting Abilities. Oxid Med Cell Longev. 2021 Jul 24;2021:7571132. doi: 10.1155/2021/7571132.</mixed-citation><mixed-citation xml:lang="en">Sharifi-Rad J, Quispe C, Herrera-Bravo J, Belén LH, Kaur R, Kregiel D, Uprety Y et al. Glycyrrhiza Genus: Enlightening Phytochemical Components for Pharmacological and Health-Promoting Abilities. Oxid Med Cell Longev. 2021 Jul 24;2021:7571132. doi: 10.1155/2021/7571132.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Wang D, Liang J, Zhang J, Wang Y, Chai X. Natural Chalcones in Chinese Materia Medica: Licorice. Evid Based Complement Alternat Med. 2020 Mar 16;2020:3821248. doi: 10.1155/2020/3821248.</mixed-citation><mixed-citation xml:lang="en">Wang D, Liang J, Zhang J, Wang Y, Chai X. Natural Chalcones in Chinese Materia Medica: Licorice. Evid Based Complement Alternat Med. 2020 Mar 16;2020:3821248. doi: 10.1155/2020/3821248.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Chen J, Yu X, Huang Y. Inhibitory mechanisms of glabridin on tyrosinase. Spectrochim Acta A Mol Biomol Spectrosc. 2016 Nov 5;168:111-117. doi: 10.1016/j.saa.2016.06.008.</mixed-citation><mixed-citation xml:lang="en">Chen J, Yu X, Huang Y. Inhibitory mechanisms of glabridin on tyrosinase. Spectrochim Acta A Mol Biomol Spectrosc. 2016 Nov 5;168:111-117. doi: 10.1016/j.saa.2016.06.008.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang D, Rasul A, Batool R, Sarfraz I, Hussain G, Mateen Tahir M, Qin T, Selamoglu Z, Ali M, Li J, Li X. Potential Anticancer Properties and Mechanisms of Action of Formononetin. Biomed Res Int. 2019 Jul 28;2019:5854315. doi: 10.1155/2019/5854315.</mixed-citation><mixed-citation xml:lang="en">Jiang D, Rasul A, Batool R, Sarfraz I, Hussain G, Mateen Tahir M, Qin T, Selamoglu Z, Ali M, Li J, Li X. Potential Anticancer Properties and Mechanisms of Action of Formononetin. Biomed Res Int. 2019 Jul 28;2019:5854315. doi: 10.1155/2019/5854315.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Z. Y., Wang L. J., Wang J. J., Feng W. J. Et al. Hispaglabridin B, a constituent of liquorice identified by a bioinformatics and machine learning approach, relieves protein-energy wasting by inhibiting forkhead box O1. Br J Pharmacol. 2019 Jan;176(2):267-281. doi: 10.1111/bph.14508.</mixed-citation><mixed-citation xml:lang="en">Huang Z. Y., Wang L. J., Wang J. J., Feng W. J. Et al. Hispaglabridin B, a constituent of liquorice identified by a bioinformatics and machine learning approach, relieves protein-energy wasting by inhibiting forkhead box O1. Br J Pharmacol. 2019 Jan;176(2):267-281. doi: 10.1111/bph.14508.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao H, Yuan X, Li D, Chen H, Jiang J, Wang Z, Sun X, Zheng Q. Isoliquiritigen enhances the antitumour activity and decreases the genotoxic effect of cyclophosphamide. Molecules. 2013 Jul 24;18(8):8786-98. doi: 10.3390/molecules18088786.</mixed-citation><mixed-citation xml:lang="en">Zhao H, Yuan X, Li D, Chen H, Jiang J, Wang Z, Sun X, Zheng Q. Isoliquiritigen enhances the antitumour activity and decreases the genotoxic effect of cyclophosphamide. Molecules. 2013 Jul 24;18(8):8786-98. doi: 10.3390/molecules18088786.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Wang KL, Yu YC, Hsia SM. Perspectives on the Role of Isoliquiritigenin in Cancer. Cancers (Basel). 2021 Jan 1;13(1):115. doi: 10.3390/cancers13010115.</mixed-citation><mixed-citation xml:lang="en">Wang KL, Yu YC, Hsia SM. Perspectives on the Role of Isoliquiritigenin in Cancer. Cancers (Basel). 2021 Jan 1;13(1):115. doi: 10.3390/cancers13010115.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Lin LC, Wu CH, Shieh TM et al. The licorice dietary component isoliquiritigenin chemosensitizes human uterine sarcoma cells to doxorubicin and inhibits cell growth by inducing apoptosis and autophagy via inhibition of m-TOR signaling. Journal of Functional Foods. 2017 Jun; 33:332-344. doi: 10.1016/j.jff.2017.03.061.</mixed-citation><mixed-citation xml:lang="en">Lin LC, Wu CH, Shieh TM et al. The licorice dietary component isoliquiritigenin chemosensitizes human uterine sarcoma cells to doxorubicin and inhibits cell growth by inducing apoptosis and autophagy via inhibition of m-TOR signaling. Journal of Functional Foods. 2017 Jun; 33:332-344. doi: 10.1016/j.jff.2017.03.061.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Peng F., Tang H., Liu P. et al. Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis. Scientific reports. 2017 Aug; 7(1):9022. doi: 10.1038/s41598-017-08422-y.</mixed-citation><mixed-citation xml:lang="en">Peng F., Tang H., Liu P. et al. Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis. Scientific reports. 2017 Aug; 7(1):9022. doi: 10.1038/s41598-017-08422-y.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Zhao H, Wang Y, Zheng H, Yu W, Chai H, Zhang J, Falck JR, Guo AM, Yue J, Peng R, Yang J. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. Toxicol Appl Pharmacol. 2013 Oct 1;272(1):37-48. doi: 10.1016/j.taap.2013.05.031.</mixed-citation><mixed-citation xml:lang="en">Li Y, Zhao H, Wang Y, Zheng H, Yu W, Chai H, Zhang J, Falck JR, Guo AM, Yue J, Peng R, Yang J. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. Toxicol Appl Pharmacol. 2013 Oct 1;272(1):37-48. doi: 10.1016/j.taap.2013.05.031.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Wang N, Wang Z, Peng C, You J, Shen J, Han S, Chen J. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling. Carcinogenesis. 2014 Nov;35(11):2544-54. doi: 10.1093/carcin/bgu187.</mixed-citation><mixed-citation xml:lang="en">Wang N, Wang Z, Peng C, You J, Shen J, Han S, Chen J. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling. Carcinogenesis. 2014 Nov;35(11):2544-54. doi: 10.1093/carcin/bgu187.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Lin P. H., Chiang Y. F., Shieh T. M. et al. Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models. Antioxidants (Basel). 2020 Mar 10;9(3):228. doi: 10.3390/antiox9030228.</mixed-citation><mixed-citation xml:lang="en">Lin P. H., Chiang Y. F., Shieh T. M. et al. Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models. Antioxidants (Basel). 2020 Mar 10;9(3):228. doi: 10.3390/antiox9030228.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Sun C, Zhang H, Ma XF, Zhou X, Gan L, Liu YY, Wang ZH. Isoliquiritigenin enhances radiosensitivity of HepG2 cells via disturbance of redox status. Cell Biochem Biophys. 2013 Apr;65(3):433-44. doi: 10.1007/s12013-012-9447-x.</mixed-citation><mixed-citation xml:lang="en">Sun C, Zhang H, Ma XF, Zhou X, Gan L, Liu YY, Wang ZH. Isoliquiritigenin enhances radiosensitivity of HepG2 cells via disturbance of redox status. Cell Biochem Biophys. 2013 Apr;65(3):433-44. doi: 10.1007/s12013-012-9447-x.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Almond J. B., Cohen G. M. The proteasome: a novel target for cancer chemotherapy. Leukemia. 2002 Apr;16(4):433-43. doi: 10.1038/sj.leu.2402417.</mixed-citation><mixed-citation xml:lang="en">Almond J. B., Cohen G. M. The proteasome: a novel target for cancer chemotherapy. Leukemia. 2002 Apr;16(4):433-43. doi: 10.1038/sj.leu.2402417.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart-Ornstein J., Lahav G. Dynamics of CDKN1A in Single Cells Defined by an Endogenous Fluorescent Tagging Toolkit. Cell Rep. 2016 Feb 23;14(7):1800-1811. doi: 10.1016/j.celrep.2016.01.045.</mixed-citation><mixed-citation xml:lang="en">Stewart-Ornstein J., Lahav G. Dynamics of CDKN1A in Single Cells Defined by an Endogenous Fluorescent Tagging Toolkit. Cell Rep. 2016 Feb 23;14(7):1800-1811. doi: 10.1016/j.celrep.2016.01.045.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Barr AR, Cooper S, Heldt FS, Butera F, Stoy H, Mansfeld J, Novák B, Bakal C. DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression. Nat Commun. 2017 Mar 20;8:14728. doi: 10.1038/ncomms14728.</mixed-citation><mixed-citation xml:lang="en">Barr AR, Cooper S, Heldt FS, Butera F, Stoy H, Mansfeld J, Novák B, Bakal C. DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression. Nat Commun. 2017 Mar 20;8:14728. doi: 10.1038/ncomms14728.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Liu F, Bardhan K, Yang D, Thangaraju M, Ganapathy V, Waller JL, Liles GB, Lee JR, Liu K. NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression. J Biol Chem. 2012 Jul 20;287(30):25530-40. doi: 10.1074/jbc.M112.356279.</mixed-citation><mixed-citation xml:lang="en">Liu F, Bardhan K, Yang D, Thangaraju M, Ganapathy V, Waller JL, Liles GB, Lee JR, Liu K. NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression. J Biol Chem. 2012 Jul 20;287(30):25530-40. doi: 10.1074/jbc.M112.356279.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Yang D, Torres CM, Bardhan K, Zimmerman M, McGaha TL, Liu K. Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo. J Immunol. 2012 May 1;188(9):4441-9. doi: 10.4049/jimmunol.1103035.</mixed-citation><mixed-citation xml:lang="en">Yang D, Torres CM, Bardhan K, Zimmerman M, McGaha TL, Liu K. Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo. J Immunol. 2012 May 1;188(9):4441-9. doi: 10.4049/jimmunol.1103035.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Weng C, Li Y, Xu D, Shi Y, Tang H. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells. J Biol Chem. 2005 Mar 18;280(11):10491-500. doi: 10.1074/jbc.M412819200.</mixed-citation><mixed-citation xml:lang="en">Weng C, Li Y, Xu D, Shi Y, Tang H. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells. J Biol Chem. 2005 Mar 18;280(11):10491-500. doi: 10.1074/jbc.M412819200.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Wahab S, Alshahrani MY, Ahmad MF, Abbas H. Current trends and future perspectives of nanomedicine for the management of colon cancer. Eur J Pharmacol. 2021 Nov 5;910:174464. doi: 10.1016/j.ejphar.2021.174464.</mixed-citation><mixed-citation xml:lang="en">Wahab S, Alshahrani MY, Ahmad MF, Abbas H. Current trends and future perspectives of nanomedicine for the management of colon cancer. Eur J Pharmacol. 2021 Nov 5;910:174464. doi: 10.1016/j.ejphar.2021.174464.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Saeedifar AM, Mosayebi G, Ghazavi A, Ganji A. Synergistic Evaluation of Ginger and Licorice Extracts in a Mouse Model of Colorectal Cancer. Nutr Cancer. 2021;73(6):1068-1078. doi: 10.1080/01635581.2020.1784440.</mixed-citation><mixed-citation xml:lang="en">Saeedifar AM, Mosayebi G, Ghazavi A, Ganji A. Synergistic Evaluation of Ginger and Licorice Extracts in a Mouse Model of Colorectal Cancer. Nutr Cancer. 2021;73(6):1068-1078. doi: 10.1080/01635581.2020.1784440.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou JX, Wink M. Reversal of Multidrug Resistance in Human Colon Cancer and Human Leukemia Cells by Three Plant Extracts and Their Major Secondary Metabolites. Medicines (Basel). 2018 Nov 13;5(4):123. doi: 10.3390/medicines5040123.</mixed-citation><mixed-citation xml:lang="en">Zhou JX, Wink M. Reversal of Multidrug Resistance in Human Colon Cancer and Human Leukemia Cells by Three Plant Extracts and Their Major Secondary Metabolites. Medicines (Basel). 2018 Nov 13;5(4):123. doi: 10.3390/medicines5040123.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Hani U, Osmani RAM, Siddiqua A. et al. A systematic study of novel drug delivery mechanisms and treatment strategies for pancreatic cancer. Journal of Drug Delivery Science and Technology. 2021 Jun; 63:102539. doi: 10.1016/j.jddst.2021.102539.</mixed-citation><mixed-citation xml:lang="en">Hani U, Osmani RAM, Siddiqua A. et al. A systematic study of novel drug delivery mechanisms and treatment strategies for pancreatic cancer. Journal of Drug Delivery Science and Technology. 2021 Jun; 63:102539. doi: 10.1016/j.jddst.2021.102539.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Yao K, Chen H, Lee MH, Li H, Ma W, Peng C, Song NR, Lee KW, Bode AM, Dong Z, Dong Z. Licochalcone A, a natural inhibitor of c-Jun N-terminal kinase 1. Cancer Prev Res (Phila). 2014 Jan;7(1):139-49. doi: 10.1158/1940-6207.</mixed-citation><mixed-citation xml:lang="en">Yao K, Chen H, Lee MH, Li H, Ma W, Peng C, Song NR, Lee KW, Bode AM, Dong Z, Dong Z. Licochalcone A, a natural inhibitor of c-Jun N-terminal kinase 1. Cancer Prev Res (Phila). 2014 Jan;7(1):139-49. doi: 10.1158/1940-6207.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma R, Santosh K. Guru, Shreyans K. Jain. et al. 3-(2, 6-Dichloro-benzyloxy)-11-oxo-olean-12-ene-29-oic acid, a semisynthetic derivative of glycyrrhetic acid: synthesis, antiproliferative, apoptotic and anti-angiogenesis activity. MedChemComm. 2015; 6(4):564-575. doi: 10.1039/C4MD00344F.</mixed-citation><mixed-citation xml:lang="en">Sharma R, Santosh K. Guru, Shreyans K. Jain. et al. 3-(2, 6-Dichloro-benzyloxy)-11-oxo-olean-12-ene-29-oic acid, a semisynthetic derivative of glycyrrhetic acid: synthesis, antiproliferative, apoptotic and anti-angiogenesis activity. MedChemComm. 2015; 6(4):564-575. doi: 10.1039/C4MD00344F.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang X, Yeung ED, Wang J, Panzhinskiy EE, Tong C, Li W, Li J. Isoliquiritigenin, a natural anti-oxidant, selectively inhibits the proliferation of prostate cancer cells. Clin Exp Pharmacol Physiol. 2010 Aug;37(8):841-7. doi: 10.1111/j.1440-1681.2010.05395.x.</mixed-citation><mixed-citation xml:lang="en">Zhang X, Yeung ED, Wang J, Panzhinskiy EE, Tong C, Li W, Li J. Isoliquiritigenin, a natural anti-oxidant, selectively inhibits the proliferation of prostate cancer cells. Clin Exp Pharmacol Physiol. 2010 Aug;37(8):841-7. doi: 10.1111/j.1440-1681.2010.05395.x.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 1992 Sep 18;70(6):993-1006. doi: 10.1016/0092-8674(92)90249-c.</mixed-citation><mixed-citation xml:lang="en">Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 1992 Sep 18;70(6):993-1006. doi: 10.1016/0092-8674(92)90249-c.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Cooley A, Zelivianski S, Jeruss JS. Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines. Cell Cycle. 2010 Dec 15;9(24):4900-7. doi: 10.4161/cc.9.24.14158.</mixed-citation><mixed-citation xml:lang="en">Cooley A, Zelivianski S, Jeruss JS. Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines. Cell Cycle. 2010 Dec 15;9(24):4900-7. doi: 10.4161/cc.9.24.14158.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Ma T, Van Tine BA, Wei Y. et al. Cell cycle-regulated phosphorylation of p220NPAT by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes &amp; development. 2000; 14(18):2298-2313. doi: 10.1101/gad.829500.</mixed-citation><mixed-citation xml:lang="en">Ma T, Van Tine BA, Wei Y. et al. Cell cycle-regulated phosphorylation of p220NPAT by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes &amp; development. 2000; 14(18):2298-2313. doi: 10.1101/gad.829500.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE, Fukasawa K. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell. 2000 Sep 29;103(1):127-40. doi: 10.1016/s0092-8674(00)00093-3.</mixed-citation><mixed-citation xml:lang="en">Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE, Fukasawa K. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell. 2000 Sep 29;103(1):127-40. doi: 10.1016/s0092-8674(00)00093-3.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993 May;7(5):812-21. doi: 10.1101/gad.7.5.812.</mixed-citation><mixed-citation xml:lang="en">Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993 May;7(5):812-21. doi: 10.1101/gad.7.5.812.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell. 1992 Oct 16;71(2):323-34. doi: 10.1016/0092-8674(92)90360-o.</mixed-citation><mixed-citation xml:lang="en">Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell. 1992 Oct 16;71(2):323-34. doi: 10.1016/0092-8674(92)90360-o.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Mushenkova NV, Bezsonov EE, Orekhova VA, Popkova TV, Starodubova AV, Orekhov AN. Recognition of Oxidized Lipids by Macrophages and Its Role in Atherosclerosis Development. Biomedicines. 2021 Jul 29;9(8):915. doi: 10.3390/biomedicines9080915.</mixed-citation><mixed-citation xml:lang="en">Mushenkova NV, Bezsonov EE, Orekhova VA, Popkova TV, Starodubova AV, Orekhov AN. Recognition of Oxidized Lipids by Macrophages and Its Role in Atherosclerosis Development. Biomedicines. 2021 Jul 29;9(8):915. doi: 10.3390/biomedicines9080915.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Reda FM, El-Saadony MT, El-Rayes TK, Farahat M, Attia G, Alagawany M. Dietary effect of licorice (Glycyrrhiza glabra) on quail performance, carcass, blood metabolites and intestinal microbiota. Poult Sci. 2021 Aug;100(8):101266. doi: 10.1016/j.psj.2021.101266.</mixed-citation><mixed-citation xml:lang="en">Reda FM, El-Saadony MT, El-Rayes TK, Farahat M, Attia G, Alagawany M. Dietary effect of licorice (Glycyrrhiza glabra) on quail performance, carcass, blood metabolites and intestinal microbiota. Poult Sci. 2021 Aug;100(8):101266. doi: 10.1016/j.psj.2021.101266.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Markina YV, Kirichenko TV, Markin AM, Yudina IY, Starodubova AV, Sobenin IA, Orekhov AN. Atheroprotective Effects of Glycyrrhiza glabra L. Molecules. 2022 Jul 22;27(15):4697. doi: 10.3390/molecules27154697.</mixed-citation><mixed-citation xml:lang="en">Markina YV, Kirichenko TV, Markin AM, Yudina IY, Starodubova AV, Sobenin IA, Orekhov AN. Atheroprotective Effects of Glycyrrhiza glabra L. Molecules. 2022 Jul 22;27(15):4697. doi: 10.3390/molecules27154697.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Honda K, Saneyasu T, Hasegawa S, Tominaga Y, Yokota S, Kamisoyama H. Effect of licorice flavonoid oil on cholesterol metabolism in high fat diet rats. Biosci Biotechnol Biochem. 2013;77(6):1326-8. doi: 10.1271/bbb.130104.</mixed-citation><mixed-citation xml:lang="en">Honda K, Saneyasu T, Hasegawa S, Tominaga Y, Yokota S, Kamisoyama H. Effect of licorice flavonoid oil on cholesterol metabolism in high fat diet rats. Biosci Biotechnol Biochem. 2013;77(6):1326-8. doi: 10.1271/bbb.130104.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Ho FM, Liao YH, Yang AJ, Lee Chao PD, Hou YC, Huang CT, et al. Anti-atherosclerotic action of Ger-Gen-Chyn-Lian-Tang and AMPK-dependent lipid lowering effect in hepatocytes. J Ethnopharmacol. 2012 Jun 26;142(1):175-87. doi: 10.1016/j.jep.2012.04.034.</mixed-citation><mixed-citation xml:lang="en">Ho FM, Liao YH, Yang AJ, Lee Chao PD, Hou YC, Huang CT, et al. Anti-atherosclerotic action of Ger-Gen-Chyn-Lian-Tang and AMPK-dependent lipid lowering effect in hepatocytes. J Ethnopharmacol. 2012 Jun 26;142(1):175-87. doi: 10.1016/j.jep.2012.04.034.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Fogelman Y, Gaitini D, Carmeli E. Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: decreased CIMT, reduced plasma lipid levels, and decreased blood pressure. Food Nutr Res. 2016 Apr 22;60:30830. doi: 10.3402/fnr.v60.30830.</mixed-citation><mixed-citation xml:lang="en">Fogelman Y, Gaitini D, Carmeli E. Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: decreased CIMT, reduced plasma lipid levels, and decreased blood pressure. Food Nutr Res. 2016 Apr 22;60:30830. doi: 10.3402/fnr.v60.30830.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Fuhrman B, Volkova N, Kaplan M, Presser D, Attias J, Hayek T, Aviram M. Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure. Nutrition. 2002 Mar;18(3):268-73. doi: 10.1016/s0899-9007(01)00753-5.</mixed-citation><mixed-citation xml:lang="en">Fuhrman B, Volkova N, Kaplan M, Presser D, Attias J, Hayek T, Aviram M. Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure. Nutrition. 2002 Mar;18(3):268-73. doi: 10.1016/s0899-9007(01)00753-5.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Luís Â, Domingues F, Pereira L. Metabolic changes after licorice consumption: A systematic review with meta-analysis and trial sequential analysis of clinical trials. Phytomedicine. 2018 Jan 15;39:17-24. doi: 10.1016/j.phymed.2017.12.010.</mixed-citation><mixed-citation xml:lang="en">Luís Â, Domingues F, Pereira L. Metabolic changes after licorice consumption: A systematic review with meta-analysis and trial sequential analysis of clinical trials. Phytomedicine. 2018 Jan 15;39:17-24. doi: 10.1016/j.phymed.2017.12.010.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Lee IT, Lee WJ, Tsai CM, Su IJ, Yen HT, Sheu WH.Combined extractives of red yeast rice, bitter gourd, chlorella, soy protein, and licorice improve total cholesterol, low-density lipoprotein cholesterol, and triglyceride in subjects with metabolic syndrome. Nutr Res. 2012 Feb;32(2):85-92. doi: 10.1016/j.nutres.2011.12.011.</mixed-citation><mixed-citation xml:lang="en">Lee IT, Lee WJ, Tsai CM, Su IJ, Yen HT, Sheu WH.Combined extractives of red yeast rice, bitter gourd, chlorella, soy protein, and licorice improve total cholesterol, low-density lipoprotein cholesterol, and triglyceride in subjects with metabolic syndrome. Nutr Res. 2012 Feb;32(2):85-92. doi: 10.1016/j.nutres.2011.12.011.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Yang L, Jiang Y, Zhang Z, Hou J, Tian S, Liu Y. The anti-diabetic activity of licorice, a widely used Chinese herb. J Ethnopharmacol. 2020 Dec 5;263:113216. doi: 10.1016/j.jep.2020.113216.</mixed-citation><mixed-citation xml:lang="en">Yang L, Jiang Y, Zhang Z, Hou J, Tian S, Liu Y. The anti-diabetic activity of licorice, a widely used Chinese herb. J Ethnopharmacol. 2020 Dec 5;263:113216. doi: 10.1016/j.jep.2020.113216.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Qi J, Cui J, Mi B, Yan X, Xu W, Ma H, Zhang Q, Xu F. Isoliquiritigenin Inhibits Atherosclerosis by Blocking TRPC5 Channel Expression. Cardiovasc Ther. 2020 Apr 7;2020:1926249. doi: 10.1155/2020/1926249.</mixed-citation><mixed-citation xml:lang="en">Qi J, Cui J, Mi B, Yan X, Xu W, Ma H, Zhang Q, Xu F. Isoliquiritigenin Inhibits Atherosclerosis by Blocking TRPC5 Channel Expression. Cardiovasc Ther. 2020 Apr 7;2020:1926249. doi: 10.1155/2020/1926249.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Ye Y, Gao M, Feng L, Feng B, Ma X. Isoliquiritigenin-induced vasodilation by activating large-conductance Ca2+ -activated K+ channels in mouse mesenteric arteries. Clin Exp Pharmacol Physiol. 2019 Nov;46(11):1044-1052. doi: 10.1111/1440-1681.13156.</mixed-citation><mixed-citation xml:lang="en">Ye Y, Gao M, Feng L, Feng B, Ma X. Isoliquiritigenin-induced vasodilation by activating large-conductance Ca2+ -activated K+ channels in mouse mesenteric arteries. Clin Exp Pharmacol Physiol. 2019 Nov;46(11):1044-1052. doi: 10.1111/1440-1681.13156.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Deutch MR, Grimm D, Wehland M, Infanger M, Krüger M. Bioactive Candy: Effects of Licorice on the Cardiovascular System. Foods. 2019 Oct 14;8(10):495. doi: 10.3390/foods8100495.</mixed-citation><mixed-citation xml:lang="en">Deutch MR, Grimm D, Wehland M, Infanger M, Krüger M. Bioactive Candy: Effects of Licorice on the Cardiovascular System. Foods. 2019 Oct 14;8(10):495. doi: 10.3390/foods8100495.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Bangert K, Kluger MA, Kluge S, Janneck M. Life-Threatening Complications of Excessive Licorice Consumption. Dtsch Arztebl Int. 2021 Dec 27;118(51-52):890-891. doi: 10.3238/arztebl.m2021.0390.</mixed-citation><mixed-citation xml:lang="en">Bangert K, Kluger MA, Kluge S, Janneck M. Life-Threatening Complications of Excessive Licorice Consumption. Dtsch Arztebl Int. 2021 Dec 27;118(51-52):890-891. doi: 10.3238/arztebl.m2021.0390.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Penninkilampi R, Eslick EM, Eslick GD. The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis. J Hum Hypertens. 2017 Nov;31(11):699-707. doi: 10.1038/jhh.2017.45.</mixed-citation><mixed-citation xml:lang="en">Penninkilampi R, Eslick EM, Eslick GD. The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis. J Hum Hypertens. 2017 Nov;31(11):699-707. doi: 10.1038/jhh.2017.45.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Tan CS, Ch’ng YS, Loh YC, Zaini Asmawi M, Ahmad M, Yam MF. Vasorelaxation effect of Glycyrrhizae uralensis through the endothelium-dependent Pathway. J Ethnopharmacol. 2017 Mar 6;199:149-160. doi: 10.1016/j.jep.2017.02.001.</mixed-citation><mixed-citation xml:lang="en">Tan CS, Ch’ng YS, Loh YC, Zaini Asmawi M, Ahmad M, Yam MF. Vasorelaxation effect of Glycyrrhizae uralensis through the endothelium-dependent Pathway. J Ethnopharmacol. 2017 Mar 6;199:149-160. doi: 10.1016/j.jep.2017.02.001.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Lien LM, Lin KH, Huang LT, Tseng MF, Chiu HC, Chen RJ, Lu WJ. Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways.Int J Mol Sci. 2017 Jul 12;18(7):1500. doi: 10.3390/ijms18071500.</mixed-citation><mixed-citation xml:lang="en">Lien LM, Lin KH, Huang LT, Tseng MF, Chiu HC, Chen RJ, Lu WJ. Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways.Int J Mol Sci. 2017 Jul 12;18(7):1500. doi: 10.3390/ijms18071500.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Yu D, Liu X, Zhang G, Ming Z, Wang T. Isoliquiritigenin Inhibits Cigarette Smoke-Induced COPD by Attenuating Inflammation and Oxidative Stress via the Regulation of the Nrf2 and NF-κB Signaling Pathways. Front Pharmacol. 2018 Sep 20;9:1001. doi: 10.3389/fphar.2018.01001.</mixed-citation><mixed-citation xml:lang="en">Yu D, Liu X, Zhang G, Ming Z, Wang T. Isoliquiritigenin Inhibits Cigarette Smoke-Induced COPD by Attenuating Inflammation and Oxidative Stress via the Regulation of the Nrf2 and NF-κB Signaling Pathways. Front Pharmacol. 2018 Sep 20;9:1001. doi: 10.3389/fphar.2018.01001.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Kim SH, Hong JH, Yang WK, Geum JH, Kim HR, Choi SY, Kang YM, An HJ, Lee YC. Herbal Combinational Medication of Glycyrrhiza glabra, Agastache rugosa Containing Glycyrrhizic Acid, Tilianin Inhibits Neutrophilic Lung Inflammation by Affecting CXCL2, Interleukin-17/STAT3 Signal Pathways in a Murine Model of COPD. Nutrients. 2020 Mar 27;12(4):926. doi: 10.3390/nu12040926.</mixed-citation><mixed-citation xml:lang="en">Kim SH, Hong JH, Yang WK, Geum JH, Kim HR, Choi SY, Kang YM, An HJ, Lee YC. Herbal Combinational Medication of Glycyrrhiza glabra, Agastache rugosa Containing Glycyrrhizic Acid, Tilianin Inhibits Neutrophilic Lung Inflammation by Affecting CXCL2, Interleukin-17/STAT3 Signal Pathways in a Murine Model of COPD. Nutrients. 2020 Mar 27;12(4):926. doi: 10.3390/nu12040926.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Dogan MF, Parlar A, Cam SA, Tosun EM, Uysal F, Arslan SO. Glabridin attenuates airway inflammation and hyperresponsiveness in a mice model of ovalbumin-induced asthma. Pulm Pharmacol Ther. 2020 Aug;63:101936. doi: 10.1016/j.pupt.2020.101936.</mixed-citation><mixed-citation xml:lang="en">Dogan MF, Parlar A, Cam SA, Tosun EM, Uysal F, Arslan SO. Glabridin attenuates airway inflammation and hyperresponsiveness in a mice model of ovalbumin-induced asthma. Pulm Pharmacol Ther. 2020 Aug;63:101936. doi: 10.1016/j.pupt.2020.101936.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Karahan F, Avsar C, Ozyigit I. I. et al. Antimicrobial and antioxidant activities of medicinal plant Glycyrrhiza glabra var. glandulifera from different habitats. Biotechnology &amp; Biotechnological Equipment. 2016 May 09;30(4):797-804. doi: 10.1080/13102818.2016.1179590.</mixed-citation><mixed-citation xml:lang="en">Karahan F, Avsar C, Ozyigit I. I. et al. Antimicrobial and antioxidant activities of medicinal plant Glycyrrhiza glabra var. glandulifera from different habitats. Biotechnology &amp; Biotechnological Equipment. 2016 May 09;30(4):797-804. doi: 10.1080/13102818.2016.1179590.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Alsayari A, Wahab S. Genus Ziziphus for the treatment of chronic inflammatory diseases. Saudi J Biol Sci. 2021 Dec;28(12):6897-6914. doi: 10.1016/j.sjbs.2021.07.076.</mixed-citation><mixed-citation xml:lang="en">Alsayari A, Wahab S. Genus Ziziphus for the treatment of chronic inflammatory diseases. Saudi J Biol Sci. 2021 Dec;28(12):6897-6914. doi: 10.1016/j.sjbs.2021.07.076.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Yang R, Yuan BC, Ma YS, Zhou S, Liu Y. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm Biol. 2017 Dec;55(1):5-18. doi: 10.1080/13880209.2016.1225775.</mixed-citation><mixed-citation xml:lang="en">Yang R, Yuan BC, Ma YS, Zhou S, Liu Y. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm Biol. 2017 Dec;55(1):5-18. doi: 10.1080/13880209.2016.1225775.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Rajagopalan P, Wahab S, Dera A. A. et al. Anti-cancer activity of ethanolic leaf extract of Salvia officinalis against oral squamous carcinoma cells in vitro via caspase mediated mitochondrial apoptosis. Pharmacognosy Magazine. 2020 Nov;16(5):546-552. doi: 10.4103/pm.pm_90_20.</mixed-citation><mixed-citation xml:lang="en">Rajagopalan P, Wahab S, Dera A. A. et al. Anti-cancer activity of ethanolic leaf extract of Salvia officinalis against oral squamous carcinoma cells in vitro via caspase mediated mitochondrial apoptosis. Pharmacognosy Magazine. 2020 Nov;16(5):546-552. doi: 10.4103/pm.pm_90_20.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Meng X, Zhang X, Su X, Liu X, Ren K, Ning C, Zhang Q, Zhang S. Daphnes Cortex and its licorice-processed products suppress inflammation via the TLR4/NF-κB/NLRP3 signaling pathway and regulation of the metabolic profile in the treatment of rheumatoid arthritis. J Ethnopharmacol. 2022 Jan 30;283:114657. doi: 10.1016/j.jep.2021.114657.</mixed-citation><mixed-citation xml:lang="en">Meng X, Zhang X, Su X, Liu X, Ren K, Ning C, Zhang Q, Zhang S. Daphnes Cortex and its licorice-processed products suppress inflammation via the TLR4/NF-κB/NLRP3 signaling pathway and regulation of the metabolic profile in the treatment of rheumatoid arthritis. J Ethnopharmacol. 2022 Jan 30;283:114657. doi: 10.1016/j.jep.2021.114657.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Vasanth MP, Purushotham KG, Sathish M. et al. Vasanth M. P. et al. In-vitro anti-inflammatory activity of liquorice (Glycyrrhiza glabra) using aqueous extract.Int. J. Res. Pharm. Sci. 2020;11:657-662. doi: 10.26452/ijrps.v11i1.1872.</mixed-citation><mixed-citation xml:lang="en">Vasanth MP, Purushotham KG, Sathish M. et al. Vasanth M. P. et al. In-vitro anti-inflammatory activity of liquorice (Glycyrrhiza glabra) using aqueous extract.Int. J. Res. Pharm. Sci. 2020;11:657-662. doi: 10.26452/ijrps.v11i1.1872.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Yu X, Bao Y, Meng X, Wang S, Li T, Chang X, Xu W, Yang G, Bo T. Multi-pathway integrated adjustment mechanism of licorice flavonoids presenting anti-inflammatory activity. Oncol Lett. 2019 Nov;18(5):4956-4963. doi: 10.3892/ol.2019.10793.</mixed-citation><mixed-citation xml:lang="en">Yu X, Bao Y, Meng X, Wang S, Li T, Chang X, Xu W, Yang G, Bo T. Multi-pathway integrated adjustment mechanism of licorice flavonoids presenting anti-inflammatory activity. Oncol Lett. 2019 Nov;18(5):4956-4963. doi: 10.3892/ol.2019.10793.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Wang HL, Li YX, Niu YT, Zheng J, Wu J, Shi GJ, Ma L, Niu Y, Sun T, Yu JQ. Observing Anti-inflammatory and Anti-nociceptive Activities of Glycyrrhizin Through Regulating COX-2 and Pro-inflammatory Cytokines Expressions in Mice. Inflammation. 2015 Dec;38(6):2269-78. doi: 10.1007/s10753-015-0212-3.</mixed-citation><mixed-citation xml:lang="en">Wang HL, Li YX, Niu YT, Zheng J, Wu J, Shi GJ, Ma L, Niu Y, Sun T, Yu JQ. Observing Anti-inflammatory and Anti-nociceptive Activities of Glycyrrhizin Through Regulating COX-2 and Pro-inflammatory Cytokines Expressions in Mice. Inflammation. 2015 Dec;38(6):2269-78. doi: 10.1007/s10753-015-0212-3.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Yin L, Guan E, Zhang Y, Shu Z, Wang B, Wu X, Chen J, Liu J, Fu X, Sun W, Liu M. Chemical Profile and Anti-inflammatory Activity of Total Flavonoids from Glycyrrhiza Uralensis Fisch. Iran J Pharm Res. 2018 Spring;17(2):726-734. PMID: 29881429.</mixed-citation><mixed-citation xml:lang="en">Yin L, Guan E, Zhang Y, Shu Z, Wang B, Wu X, Chen J, Liu J, Fu X, Sun W, Liu M. Chemical Profile and Anti-inflammatory Activity of Total Flavonoids from Glycyrrhiza Uralensis Fisch. Iran J Pharm Res. 2018 Spring;17(2):726-734. PMID: 29881429.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X, Zhu Q, Zhang M, Yin T, Xu R, Xiao W, Wu J, Deng B, Gao X, Gong W, Lu G, Ding Y. Isoliquiritigenin Ameliorates Acute Pancreatitis in Mice via Inhibition of Oxidative Stress and Modulation of the Nrf2/HO-1 Pathway. Oxid Med Cell Longev. 2018 Apr 26;2018:7161592. doi: 10.1155/2018/7161592.</mixed-citation><mixed-citation xml:lang="en">Liu X, Zhu Q, Zhang M, Yin T, Xu R, Xiao W, Wu J, Deng B, Gao X, Gong W, Lu G, Ding Y. Isoliquiritigenin Ameliorates Acute Pancreatitis in Mice via Inhibition of Oxidative Stress and Modulation of the Nrf2/HO-1 Pathway. Oxid Med Cell Longev. 2018 Apr 26;2018:7161592. doi: 10.1155/2018/7161592.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang M, Wu YQ, Xie L, Wu J, Xu K, Xiao J, Chen DQ. Corrigendum: Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling. Front Pharmacol. 2019 Jul 12;10:788. doi: 10.3389/fphar.2019.00788.</mixed-citation><mixed-citation xml:lang="en">Zhang M, Wu YQ, Xie L, Wu J, Xu K, Xiao J, Chen DQ. Corrigendum: Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling. Front Pharmacol. 2019 Jul 12;10:788. doi: 10.3389/fphar.2019.00788.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Tang Y, Wang C, Wang Y, Zhang J, Wang F, Li L, Meng X, Li G, Li Y, Wang L. Isoliquiritigenin attenuates LPS-induced AKI by suppression of inflammation involving NF-κB pathway. Am J Transl Res. 2018 Dec 15;10(12):4141-4151.</mixed-citation><mixed-citation xml:lang="en">Tang Y, Wang C, Wang Y, Zhang J, Wang F, Li L, Meng X, Li G, Li Y, Wang L. Isoliquiritigenin attenuates LPS-induced AKI by suppression of inflammation involving NF-κB pathway. Am J Transl Res. 2018 Dec 15;10(12):4141-4151.</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao H, Zhang N, Ho V, Ding M, He W, Niu J, Yang M, Du XL, Zorzi D, Chavez-MacGregor M, Giordano SH. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011. Cancer. 2018 Feb 15;124(4):679-687. doi: 10.1002/cncr.31094.</mixed-citation><mixed-citation xml:lang="en">Zhao H, Zhang N, Ho V, Ding M, He W, Niu J, Yang M, Du XL, Zorzi D, Chavez-MacGregor M, Giordano SH. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011. Cancer. 2018 Feb 15;124(4):679-687. doi: 10.1002/cncr.31094.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Xiong D, Hu W, Ye ST, Tan YS. Isoliquiritigenin alleviated the Ang II-induced hypertensive renal injury through suppressing inflammation cytokines and oxidative stress-induced apoptosis via Nrf2 and NF-κB pathways. Biochem Biophys Res Commun. 2018 Nov 17;506(1):161-168. doi: 10.1016/j.bbrc.2018.09.013.</mixed-citation><mixed-citation xml:lang="en">Xiong D, Hu W, Ye ST, Tan YS. Isoliquiritigenin alleviated the Ang II-induced hypertensive renal injury through suppressing inflammation cytokines and oxidative stress-induced apoptosis via Nrf2 and NF-κB pathways. Biochem Biophys Res Commun. 2018 Nov 17;506(1):161-168. doi: 10.1016/j.bbrc.2018.09.013.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Jia T, Qiao J, Guan D et al. Anti-Inflammatory Effects of Licochalcone A on IL-1β-Stimulated Human Osteoarthritis Chondrocytes. Inflammation. 2017 Jul 29;40:1894-1902. doi: 10.1007/s10753-017-0630-5.</mixed-citation><mixed-citation xml:lang="en">Jia T, Qiao J, Guan D et al. Anti-Inflammatory Effects of Licochalcone A on IL-1β-Stimulated Human Osteoarthritis Chondrocytes. Inflammation. 2017 Jul 29;40:1894-1902. doi: 10.1007/s10753-017-0630-5.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Franceschelli S, Pesce M, Ferrone A, Gatta DM, Patruno A, Lutiis MA, Quiles JL, Grilli A, Felaco M, Speranza L. Biological Effect of Licochalcone C on the Regulation of PI3K/Akt/eNOS and NF-κB/iNOS/NO Signaling Pathways in H9c2 Cells in Response to LPS Stimulation.Int J Mol Sci. 2017 Mar 23;18(4):690. doi: 10.3390/ijms18040690.</mixed-citation><mixed-citation xml:lang="en">Franceschelli S, Pesce M, Ferrone A, Gatta DM, Patruno A, Lutiis MA, Quiles JL, Grilli A, Felaco M, Speranza L. Biological Effect of Licochalcone C on the Regulation of PI3K/Akt/eNOS and NF-κB/iNOS/NO Signaling Pathways in H9c2 Cells in Response to LPS Stimulation.Int J Mol Sci. 2017 Mar 23;18(4):690. doi: 10.3390/ijms18040690.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
